Bisocor™ Plus
Bisoprolol Fumarate+ Hydrochlorothiazide
Beta Blocker Diuretic Combination (Cardiovascular Preparations)
Indication:
Management of Hypertension
Dosage & Administration:
Bisoprolol is an effective treatment of hypertension in once daily doses of 2.5 to 40 mg, while Hydrochlorothiazide is effective in doses of 12.5 to 50 mg.
In clinical trials of Bisoprolol/Hydrochlorothiazide combination therapy using Bisoprolol doses of 2.5 to 20 mg and Hydrochlorothiazide doses of 6.25 to 25 mg, the antihypertensive effects increased with increasing doses of either component.
Initial Therapy: Antihypertensive therapy may be initiated with the lowest dose of Bisoprolol is an effective treatment of hypertension in once daily doses of 2.5 to 40 mg, while Hydrochlorothiazide is effective in doses of 12.5 to 50 mg.
In clinical trials of Bisoprolol/Hydrochlorothiazide combination therapy using Bisoprolol doses of 2.5 to 20 mg and Hydrochlorothiazide doses of 6.25 to 25 mg, the antihypertensive effects increased with increasing doses of either component.
Initial Therapy: Antihypertensive therapy may be initiated with the lowest dose of Bisoprolol is an effective treatment of hypertension in once daily doses of 2.5 to 40 mg, while Hydrochlorothiazide is effective in doses of 12.5 to 50 mg.
In clinical trials of Bisoprolol/Hydrochlorothiazide combination therapy using Bisoprolol doses of 2.5 to 20 mg and Hydrochlorothiazide doses of 6.25 to 25 mg, the antihypertensive effects increased with increasing doses of either component.
Initial Therapy: Antihypertensive therapy may be initiated with the lowest dose of Bisocor™ Plus, one 2.5/6.25 mg tablet once daily. Subsequent titration (14 day intervals) may be carried out with Bisocor™ Plus tablets up to the maximum recommended dose 20/12.5 mg once daily, as appropriate.
, one 2.5/6.25 mg tablet once daily. Subsequent titration (14 day intervals) may be carried out with Bisocor™ Plus tablets up to the maximum recommended dose 20/12.5 mg once daily, as appropriate.
, one 2.5/6.25 mg tablet once daily. Subsequent titration (14 day intervals) may be carried out with Bisocor™ Plus tablets up to the maximum recommended dose 20/12.5 mg once daily, as appropriate.
Preparation:
Bisocor™ Plus 2.5/6.25 tablet: Each box contains 30 tablets in blister pack.
Bisocor™ Plus 5/6.25 tablet: Each box contains 30 tablets in blister pack.
